Human prothrombin complex concentrate (Harbin Shiheng Bioengineering Pharmaceutical)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex concentrate (Harbin Shiheng Bioengineering Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHarbin Pacific Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Shiheng Bioengineering Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia